Noninvasive and minimally invasive detection and monitoring of peripheral neuropathies

References

• Boulton AJ. Whither clinical research in diabetic sensorimotor peripheral neuropathy? Problems of end point selection for clinical trials. Diabetes Care30(10), 2752–2753 (2007).
   PubMedGoogle Scholar
• Herrmann DN, Bromberg MB. Chili peppers, nerve regeneration and clinical trial design. Neurology68(16), 1247–1248 (2007).
   PubMedGoogle Scholar
• England JD, Gronseth GS, Franklin G et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology64(2), 199–207 (2005).
   PubMed Web of Science ®Google Scholar
• Apfel SC, Asbury AK, Bril V et al. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials: ad hoc panel on endpoints for diabetic neuropathy trials. J. Neurol. Sci.189(1–2), 3–5 (2001).
   PubMedGoogle Scholar
• Dworkin RH, Turk DC, Farrar JT et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain113(1–2), 9–19 (2005).
   PubMed Web of Science ®Google Scholar
• Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology48(2), 332–338 (1997).
   PubMed Web of Science ®Google Scholar
• Bastyr EJ 3rd, Price KL, Bril V; the MBBQ Study Group. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin. Ther.27(8), 1278–1294 (2005).
   PubMed Web of Science ®Google Scholar
• Grant IA, O’Brien P, Dyck PJ. Neuropathic assessment. In: Diabetic Neuropathy (2nd Edition). Dyck PJ, Thomas Pk (Eds.). WB Saunders Company, PA, USA (1999).
   Google Scholar
• Dyck PJ, O’Brien PC, Litchy WJ, Harper CM, Klein CJ, Dyck PJ. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy. Diabetes Care28(9), 2192–2200 (2005).
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Norell JE, Tritschler H et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care30(10), 2619–2625 (2007).
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Davies JL, Litchy WJ, O’Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology49(1), 229–239 (1997).
   PubMed Web of Science ®Google Scholar
• Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care17(11), 1281–1289 (1994).
   PubMed Web of Science ®Google Scholar
• Bril V, Perkins BA. Validation of the Toronto clinical scoring system for diabetic polyneuropathy. Diabetes Care25(11), 2048–2052 (2002).
   PubMed Web of Science ®Google Scholar
• Position statement: standards of medical care in diabetes American Diabetes Association. Diabetes Care27(S1), 15–35 (2004).
   PubMedGoogle Scholar
• Cornblath DR, Chaudhry V, Carter K et al. Total neuropathy score: validation and reliability study. Neurology53(8), 1660–1664 (1999).
   PubMed Web of Science ®Google Scholar
• Shy ME, Chen L, Swan ER et al. Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology70(5), 378–383 (2008).
   PubMed Web of Science ®Google Scholar
• Shy ME, Blake J, Krajewski K et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology64(7), 1209–1214 (2005).
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Tandan R, Bastyr EJ 3rd et al. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials. Diabetes Care30(10), 2626–2632 (2007).
   PubMed Web of Science ®Google Scholar
• Bird SJ, Brown MJ, Spino C, Watling S, Foyt HL. Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial. Muscle Nerve34(2), 214–224 (2006).
   PubMed Web of Science ®Google Scholar
• Rappaport BA. Current FDA Policy on analgesic drug and biologic product development. Presented at: 10th International Conference on the Mechanisms and Treatment of Neuropathic Pain. Snowbird, UT, USA, 2 November, 2007.
   Google Scholar
• Quattrini C, Tavakoli M, Jeziorska M et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes56(8), 2148–2154 (2007).
   PubMed Web of Science ®Google Scholar
• Herrmann DN, Ferguson ML, Pannoni V et al. The plantar nerve AP and skin biopsy in sensory neuropathies with normal routine conduction studies. Neurology63(5), 879–885 (2004).
   PubMed Web of Science ®Google Scholar
• Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology53(8), 1634–1640 (1999).
   PubMed Web of Science ®Google Scholar
• Suarez GA, Dyck PJ. Quantitative sensory assessment. In: Diabetic Neuropathy (2nd Edition). Dyck PJ, Thomas PK (Eds). WB Saunders Company, PA, USA (1999).
   Google Scholar
• Gruener G, Dyck PJ. Quantitative sensory testing: methodology, applications, and future directions. J. Clin. Neurophysiol.11(6), 568–583 (1994).
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Dyck PJ, Kennedy WR et al. Limitations of quantitative sensory testing when patients are biased toward a bad outcome. Neurology50(5), 1213 (1998).
   PubMedGoogle Scholar
• Dyck PJ, O’Brien PC. Quantitative sensation testing in small-diameter sensory fiber neuropathy. Muscle Nerve26(5), 595–596 (2002).
   PubMed Web of Science ®Google Scholar
• Shy ME, Frohman EM, So YT et al. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology60(6), 898–904 (2003).
   PubMed Web of Science ®Google Scholar
• Chong PS, Cros DP. Technology literature review: quantitative sensory testing. Muscle Nerve29(5), 734–747 (2004).
   PubMed Web of Science ®Google Scholar
• Periquet MI, Novak V, Collins MP et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology53(8), 1641–1647 (1999).
   PubMed Web of Science ®Google Scholar
• Berger AR, Arezzo JC, Schaumburg HH et al. 2´,3´-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology43(2), 358–362 (1993).
   PubMed Web of Science ®Google Scholar
• Brown MJ, Bird SJ, Watling S et al. Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Zenarest study. Diabetes Care27(5), 1153–1159 (2004).
   PubMedGoogle Scholar
• Herrmann DN, McDermott MP, Henderson D et al. Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy. Muscle Nerve.29(3), 420–427 (2004).
   PubMedGoogle Scholar
• Simpson DM, Kitch D, Evans SR et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology66(11), 1679–1687 (2006).
   PubMed Web of Science ®Google Scholar
• Herrmann DN, McDermott MP, Sowden JE et al. Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? A longitudinal study. Neurology66(6), 857–861 (2006).
   PubMedGoogle Scholar
• Chaudhry V, Eisenberger MA, Sinibaldi VJ, Sheikh K, Griffin JW, Cornblath DR. A prospective study of suramin-induced peripheral neuropathy. Brain119(6), 2039–2052 (1996).
   PubMedGoogle Scholar
• Chaudhry V, Cornblath DR, Corse A, Freimer M, Simmons-O’Brien E, Vogelsang G. Thalidomide-induced neuropathy. Neurology59(12), 1872–1875 (2002).
   PubMed Web of Science ®Google Scholar
• Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann. Neurol.35(3), 304–311 (1994).
   PubMed Web of Science ®Google Scholar
• Apfel SC, Schwartz S, Adornato BT et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA284(17), 2215–2221 (2000).
   PubMed Web of Science ®Google Scholar
• Schifitto G, Yiannoutsos C, Simpson DM et al. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology57(7), 1313–1316 (2001).
   PubMed Web of Science ®Google Scholar
• Hilz MJ, Brys M, Marthol H, Stemper B, Dutsch M. Enzyme replacement therapy improves function of C-, Aδ- and Aβ-nerve fibers in Fabry neuropathy. Neurology62(7), 1066–1072 (2004).
   PubMedGoogle Scholar
• Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J. Fam. Pract.49(11 Suppl.), S17–S29 (2000).
   PubMed Web of Science ®Google Scholar
• Coppini DV, Young PJ, Weng C, Macleod AF, Sönksen PH. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case–control study. Diabet. Med.15(9), 765–771 (1998).
   PubMedGoogle Scholar
• Rolke R, Baron R, Maier C et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain123(3), 231–243 (2006).
   PubMed Web of Science ®Google Scholar
• Treede RD, Lorenz J, Baumgärtner U. Clinical usefulness of laser-evoked potentials. Neurophysiol. Clin.33(6), 303–314 (2003).
   PubMedGoogle Scholar
• Pozzessere G, Rossi P, Gabriele A et al. Early detection of small-fiber neuropathy in diabetes: a laser-induced pain somatosensory-evoked potentials and pupillometric study. Diabetes Care25(12), 2355–2358 (2002).
   PubMed Web of Science ®Google Scholar
• Atherton DD, Facer P, Roberts KM et al. Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fiber neuropathy: correlations with skin flare responses and intra-epidermal nerve fiber counts. BMC Neurol.7, 21 (2007).
   PubMed Web of Science ®Google Scholar
• Chao CC, Hsieh SC, Tseng MT, Chang YC, Hsieh ST. Patterns of contact heat evoked potentials (CHEP) in neuropathy with skin denervation: correlation of CHEP amplitude with intra-epidermal nerve fiber density. Clin. Neurophysiol.119(3), 653–661 (2008).
   PubMed Web of Science ®Google Scholar
• Obermann M, Katsarava Z, Esser S et al. Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy. Pain138(1), 79–86 (2008).
   PubMedGoogle Scholar
• McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch. Neurol.55(12), 1513–1520 (1998).
   PubMed Web of Science ®Google Scholar
• Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology47(4), 1042–1048 (1996).
   PubMed Web of Science ®Google Scholar
• Smith AG, Howard JR, Kroll R et al. The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J. Neurol. Sci.228(1), 65–69 (2005).
   PubMedGoogle Scholar
• Koskinen M, Hietaharju A, Kyläniemi M et al. A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J. Neurol.252(7), 789–794 (2005).
   PubMed Web of Science ®Google Scholar
• Devigili G, Tugnoli V, Penza P et al. The diagnostic criteria for small fiber neuropathy: from symptoms to neuropathology. Brain131(7), 1912–1925 (2008).
   PubMed Web of Science ®Google Scholar
• Lauria G, Cornblath DR, Johansson O et al. European Federation of Neurological Societies. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur. J. Neurol.12(10), 747–758 (2005).
   PubMed Web of Science ®Google Scholar
• Polydefkis M, Yiannoutsos CT, Cohen BA et al. Reduced intra-epidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology58(1), 115–119 (2002).
   PubMed Web of Science ®Google Scholar
• Shun CT, Chang YC, Wu HP et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain127(7), 1593–1605 (2004).
   PubMed Web of Science ®Google Scholar
• Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjogren syndrome. Neurology65(6), 925–927 (2005).
   PubMedGoogle Scholar
• McCarthy BG, Hsieh ST, Stocks A et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology45(10), 1848–1855 (1995).
   PubMed Web of Science ®Google Scholar
• Holland NR, Crawford TO, Hauer P et al. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann. Neurol.44(1), 47–59 (1998).
   PubMed Web of Science ®Google Scholar
• Løseth S, Lindal S, Stålberg E, Mellgren SI. Intraepidermal nerve fiber density, quantitative sensory testing and nerve conduction studies in a patient material with symptoms and signs of sensory polyneuropathy. Eur. J. Neurol.13(2), 105–111 (2006).
   PubMed Web of Science ®Google Scholar
• Schiffmann R, Hauer P, Freeman B et al. Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve34(1), 53–56 (2006).
   PubMed Web of Science ®Google Scholar
• Lauria G, Morbin M, Lombardi R et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology61(5), 631–636 (2003).
   PubMed Web of Science ®Google Scholar
• Vlcková-Moravcová E, Bednarík J, Dusek L, Toyka KV, Sommer C. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve37(1), 50–60 (2008).
   PubMedGoogle Scholar
• Ebenezer GJ, McArthur JC, Thomas D et al. Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. Brain130(10), 2703–2714 (2007).
   PubMed Web of Science ®Google Scholar
• Li J, Bai Y, Ghandour K et al. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain128(5), 1168–1177 (2005).
   PubMed Web of Science ®Google Scholar
• Sabet A, Li J, Ghandour K et al. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B. Neurology67(7), 1141–1146 (2006).
   PubMedGoogle Scholar
• Lombardi R, Erne B, Lauria G et al. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy. Ann. Neurol.57(2), 163–167 (2005).
   PubMedGoogle Scholar
• Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain127(7), 1606–1615 (2004).
   PubMed Web of Science ®Google Scholar
• Hahn K, Sirdofsky M, Brown A et al. Collateral sprouting of human epidermal nerve fibers following intracutaneous axotomy. J. Peripher. Nerv. Syst.11(2), 142–147 (2006).
   PubMedGoogle Scholar
• Polydefkis M, Sirdofsky M, Hauer P et al. Factors influencing nerve regeneration in a trial of timcodar dimesylate. Neurology66(2), 259–261 (2006).
   PubMedGoogle Scholar
• Hahn K, Triolo A, Hauer P et al. Impaired reinnervation in HIV infection following experimental denervation. Neurology68(16), 1251–1256 (2007).
   PubMedGoogle Scholar
• Hossain P, Sachdev A, Malik RA et al. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet366(9494), 1340–1343 (2005).
   PubMed Web of Science ®Google Scholar
• Mehra S, Tavakoli M, Kallinikos PA et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with Type 1 diabetes. Diabetes Care30(10), 2608–2612 (2007).
   PubMed Web of Science ®Google Scholar
• Rajadhyaksha M, Gonzalez S, Zavislan JM, Anderson RR, Webb RH. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology. J. Invest. Dermatol.113(3), 293–303 (1999).
   PubMed Web of Science ®Google Scholar
• Busam K, Hester K, Charles C et al. Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy (CSLM). Arch. Dermatol.137(7), 923–929 (2001).
   PubMed Web of Science ®Google Scholar
• Langley R, Rajadhyaksha M, Dwyer P, Sober A, Flotte T, Anderson RR. Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo. J. Am. Acad. Dermatol.45(3), 365–376 (2001).
   PubMed Web of Science ®Google Scholar
• Bolton C, Winkelmann R, Dyck P. A quantitative study of Meissner’s corpuscles in man. Neurology16(1), 1–9 (1966).
   PubMed Web of Science ®Google Scholar
• Pare M, Elde R, Mazurkiewicz JE, Smith AM, Rice FL. The Meissner corpuscle revised: a multiafferented mechanoreceptor with nociceptor immunochemical properties. J. Neurosci.21(18), 7236–7246 (2001).
   PubMed Web of Science ®Google Scholar
• Nolano M, Provitera V, Crisci C et al. Quantification of myelinated endings and mechanoreceptors in human digital skin. Ann. Neurol.54(2) 197–205 (2003).
   PubMedGoogle Scholar
• Nolano M, Provitera V, Lullo F et al. Meissner corpuscles and myelinated nerve fibers in human digital skin: a correlation with electrophysiological findings. J. Peripher. Nerv. Syst.6(3), 165 (2001).
   Google Scholar
• Nolano M, Provitera V, Lullo F et al. Tactile stimulation and mechanoreceptors in sensory neuropathies. Neurol. Sci.22(1), S31–S36 (2001).
   PubMedGoogle Scholar
• Jabaley ME, Burns JE, Orcutt BS, Bryant M. Comparison of histologic and functional recovery after peripheral nerve repair. J. Hand Surg. [Am.]1(2), 119–130 (1976).
   PubMedGoogle Scholar
• Hsieh ST, Chu NS. Immunohistochemical study of skin nerve regeneration after toe-to-finger transplantation: correlations with clinical, quantitative sensory, and electrophysiological evaluations. Acta Neurol. Taiwan13(4), 178–185 (2004).
   PubMedGoogle Scholar
• Herrmann DN, Boger NJ, Jansen C, Alessi-Fox C. In vivo confocal microscopy of Meissner’s corpuscles as a measure of sensory neuropathy. Neurology69(23), 2121–2127 (2007).
   PubMedGoogle Scholar
• Peripheral Neuropathy Course syllabus. American Academy of Neurology Annual Meeting. San Diego, CA, USA, 1–8 April 2006 (7FC.002–91).
   Google Scholar